DrugClaw
Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware.
DrugClaw is worth your time if you already run a Linux or Windows workstation with Rust and Node.js toolchains and you need compound data to stay inside your own network. The drugclaw doctor check and the one-liner installer lower the setup bar compared with a raw source build, and Docker-sandboxed screening runs give you an isolation story that hosted tools rarely document in public. If your team has no DevOps capacity, or you need a vendor SLA behind the tool, DrugClaw is the wrong shape of product — a commercial platform will cost money but cover that gap.
Verified 4d ago · liveness 45/100 · cite: rightaichoice.com/tools/drugclaw
- Computational biologists who need molecular property prediction on private compound data
- Medicinal chemists running virtual screening in-house
- AI researchers building custom drug discovery workflows
- Drug discovery startups that can maintain their own Linux or Windows infrastructure
- Teams with no engineering capacity to install and maintain a self-hosted stack
- Researchers who need a vendor SLA or formal support contract
- Groups that require a shared multi-user web deployment out of the box
We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.
- Honest verdict, not marketing
- Real pros & cons from real users
- Attributed quotes with receipts
3 free scans · no card needed
Skip DrugClaw if nobody on your team can own a Rust/Node.js installation and patching cycle, or if you need vendor support behind the tool rather than a repository you maintain yourself.
Self-hosting means you pay for the compute, storage and GPU time yourself — the zero licensing cost is offset by infrastructure you now own.
DrugClaw is published as open source with no licence fee, which puts it at the opposite end of the market from commercial drug discovery platforms that charge per seat or per compute allocation. The trade is maintenance: you fund the servers, the Docker host and the engineering hours instead of a subscription, so the total cost favours small academic and startup groups that already run their own compute, and penalises teams that would otherwise buy a support contract.
In short
DrugClaw — Open-source, self-hosted AI research assistant for drug discovery — molecular property prediction, virtual screening and PK/PD modeling on your own hardware. Best for Computational biologists who need molecular property prediction on private compound data, Medicinal chemists running virtual screening in-house, AI researchers building custom drug discovery workflows. Free to use.
What people actually say about DrugClaw — is it worth it?
We ran a structured research pass across product reviews, community discussions, and post-purchase forum threads to surface the patterns vendors won't publish themselves. Below: the recurring strengths, the hidden costs people mention most, and the cohort that consistently regrets adopting this tool.
2 mentions across 2 sources (Bluesky, GitHub) · researched Jul 5, 2026.
Average across the 2 sources that answered — each source counts once, not each post.
- +Completely free and open-source with no hidden paywalls.
- +Modular plugin architecture allows custom workflow extensions.
- +Covers 57 skills across 15 drug discovery task categories.
- +Integrates Docker sandboxes for safe simulation execution.
- +Offers both CLI and web UI for flexibility.
- −Very limited community feedback – only 2 data points found.
- −Installation requires Rust and Node.js compilation skills.
- −No official support channels or community forums evident.
- −Dependency on LangGraph may cause version conflicts.
- −No clear documentation or tutorials available.
- • No hidden costs, but requires personal server or Docker host.
- • Time cost for setup and maintenance.
Viability Score
How well maintained and how widely used is DrugClaw? Built from what the vendor actually publishes (docs, changelog, tutorials, integrations, pricing), whether the site is live, and how much real users discuss it. How we calculate this
Last calculated: October 2026
How we score →Key Features
- Molecular property prediction on custom compound libraries
- Virtual screening workflows
- PK/PD prediction
- Literature mining and summarization
- Custom workflow creation via plugin architecture
- Docker sandbox isolation for simulations (drug-sandbox image)
- Command-line interface
- Web UI served locally on 127.0.0.1:10961
- Rust backend with Node.js web front end
- One-liner install script for Linux (curl | bash)
- One-liner install script for Windows (iwr | iex)
- drugclaw doctor environment troubleshooting command
- YAML configuration file (drugclaw.config.yaml)
- Self-hosted deployment with full data control
- Interface in Simplified Chinese, Traditional Chinese, and English
About DrugClaw
DrugClaw is an open-source AI research assistant built for drug discovery teams that want to run everything on their own infrastructure. It covers molecular property prediction, virtual screening, PK/PD prediction, and literature mining, and you drive it either from a command-line interface or from a web UI served locally on port 10961. Installation is a one-liner: a curl pipe to bash on Linux or an iwr/iex PowerShell command on Windows, plus a documented source build path using cargo for the Rust backend and npm for the web front end. A drugclaw doctor command checks your configuration before you start, and a drugclaw.config.yaml file holds your settings. Workflows can be extended through a plugin architecture, and virtual screening jobs can be isolated inside a Docker sandbox image built from docker/drug-sandbox.Dockerfile. The interface supports Simplified Chinese, Traditional Chinese, and English. DrugClaw suits computational biologists, medicinal chemists, and AI researchers who are comfortable with Rust, Node.js, and Docker and who need compound data to stay on their own machines, rather than teams looking for a hosted platform with a support contract.
Behind the Verdict
The pitch here is narrow and honest: DrugClaw is an open-source research assistant you host yourself, aimed at computational biologists, medicinal chemists, and AI researchers working on drug discovery problems. Four capability areas are named on the site — molecular property prediction, virtual screening, PK/PD prediction, and literature mining — and you can chain them into custom workflows through a plugin architecture rather than being locked to a fixed pipeline. Two interfaces ship: a CLI and a web UI on 127.0.0.1:10961, which is where the practical friction lives. Because the web UI binds to localhost by default, a lab or a team has to put its own reverse proxy or network access in front of it before anyone other than the person at that machine can use it. That is a configuration job, not a bug, but it is the first thing a team will hit. Setup itself is well signposted. There is an install script for Linux (curl -fsSL https://drugclaw.com/install.sh | bash) and one for Windows (iwr https://drugclaw.com/install.ps1 -UseBasicParsing | iex), a config example file, a drugclaw setup step, and a drugclaw doctor command to diagnose a bad environment before you start a run. Building from source is documented too: clone the GitHub repository, cargo build for the Rust backend, then npm install and npm run build inside the web directory. Docker is optional but meaningful — the drug-sandbox image, built from docker/drug-sandbox.Dockerfile, is what lets you run simulations in an isolated container rather than on the host. Where DrugClaw asks the most of you is long-term ownership. No managed cloud service is offered, so hardware, upgrades, and keeping the stack patched are yours. The web UI is local by default. There is no official enterprise support or SLA on the public site. For a small research group that already treats infrastructure as part of the job, all of that is a fair trade for zero licensing cost and full visibility into the code. For a team whose scientists expect to sign in to a URL and file a ticket when something breaks, the maintenance load will land on whoever volunteered first. Treat DrugClaw as a foundation you build on rather than a finished platform, and scope a week of engineering time for the first deployment.
Researching DrugClaw? Get your full AI stack in 60 seconds.
Free, no signup — tell us your goal and get tools matched to your budget & existing stack.
Real-world workflow fit
Concrete scenarios for the personas DrugClaw actually fits — and what changes day-one when you adopt it.
Installs DrugClaw on a lab workstation with the Linux one-liner, runs drugclaw doctor to confirm the environment, then points the CLI at a private compound set for molecular property prediction.
Outcome: Property predictions land without any compound structure leaving the lab network, and the config file makes the run reproducible for the next student.
Builds the drug-sandbox Docker image and runs a virtual screening pass isolated in a container, then opens the web UI on 127.0.0.1:10961 to review candidates and PK/PD profiles.
Outcome: A shortlist of candidates comes back in an afternoon, with the screening environment contained so a bad run cannot touch the host machine.
Uses the plugin architecture and the Rust backend to add a custom scoring step, then calls the workflow from the CLI so it slots into an existing CADD pipeline.
Outcome: Custom scoring becomes a repeatable step in the pipeline instead of a one-off notebook, and the source is readable when results need auditing.
Use Cases
- Predict molecular properties across an in-house compound library from the CLI
- Run virtual screening jobs inside the Docker drug-sandbox so simulations stay isolated from the host
- Mine and summarize drug discovery literature without sending documents to a third-party service
- Model PK/PD profiles for candidate molecules you cannot upload to a hosted platform
- Extend the plugin architecture to wire DrugClaw outputs into an existing CADD pipeline
- Stand up a shared instance behind your own network so a lab can review candidates through the web UI
Limitations
- DrugClaw is self-hosted only: you install it yourself, either with the one-liner script or by building from source with cargo and npm, and you supply and maintain the hardware.
- The web UI binds to 127.0.0.1:10961 by default, so making it reachable to a team means adding your own proxy or network configuration.
- There is no managed cloud option and no official enterprise support or SLA documented on the public site.
- Virtual screening isolation depends on you building and running the Docker drug-sandbox image.
- Multi-user access control and shared workspaces are not described in the public material, so treat DrugClaw as a personal or lab-machine tool until you engineer otherwise.
as of 2026-10-04
Verification history
We have re-verified DrugClaw 9 times since . Each pass re-reads the vendor's own pages and re-checks every listed field against that evidence; passes where nothing had changed are marked as such.
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
- — re-checked, vendor evidence unchanged
Showing the 6 most recent of 9 verification passes.
Free to cite with attribution — this page re-verifies continuously.
Where the pricing makes sense
The company stage and team size where DrugClaw's pricing actually pencils out — and where peers do it cheaper.
DrugClaw is published as open source with no licence fee, which puts it at the opposite end of the market from commercial drug discovery platforms that charge per seat or per compute allocation. The trade is maintenance: you fund the servers, the Docker host and the engineering hours instead of a subscription, so the total cost favours small academic and startup groups that already run their own compute, and penalises teams that would otherwise buy a support contract.
Setup time & first value
How long it actually takes to get something useful out of DrugClaw — broken out by persona, not the marketing-page minute.
With the install one-liner and drugclaw doctor, a comfortable Linux user can get to a first CLI run in under an hour; Windows via the PowerShell script is similar. A shared deployment is the slow part: budget a few days of engineer time to build from source with cargo and npm, build the Docker sandbox image, and put a reverse proxy in front of the localhost-only web UI.
Switching to or from DrugClaw
How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.
- →From a hosted drug discovery SaaS: export your compound sets and literature corpora, run the install script on internal hardware, and rebuild your scoring steps as DrugClaw workflows so no structures leave your network.
- →From a hand-rolled Python or Java molecular modelling pipeline: map each script to a DrugClaw CLI step or plugin, then chain them into a single custom workflow.
- →From a lab notebook plus spreadsheet screening process: build the drug-sandbox Docker image, run your compound library through virtual screening, and review hits in the web UI on port 10961.
- ↗To a commercial discovery platform: export results from the CLI and rebuild your scoring parameters in the vendor's workflow builder — expect to re-implement any custom plugin logic by hand.
- ↗To a general-purpose chemistry toolkit: the molecular property and PK/PD steps have equivalents, but the plugin architecture and sandboxed screening have no direct drop-in replacement.
- ↗To another self-hosted stack: the configuration is a YAML file and the workflows are CLI-driven, so the migration cost is mostly re-writing your Docker sandbox and pipeline glue.
Resources & Guides
Tutorials & Learning
YouTube returned 6 videos for “DrugClaw”, and we withheld 6: 6 could not be judged, because “DrugClaw” is a single word that other videos use for other things. We are showing none, because we could not prove any of them are about DrugClaw.
Official links
Tools that pair well with DrugClaw
Common stack mates teams adopt alongside DrugClaw, with the specific reason each pairing earns its keep.
Insilico Medicine
Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.
Schrodinger
Physics-based molecular simulation with AI for drug discovery and materials design.
Owkin
Owkin's K Pro is an autonomous AI scientist agent for biopharma R&D, turning multimodal patient data into drug discovery and clinical trial
Featured Head-to-Head Comparisons
Drugclaw vs Isomorphic Labs
Choose Isomorphic Labs if you are a large pharma company seeking deep AI-driven drug discovery partnerships with access to cutting-edge predictive and generative models built on AlphaFold, and you have the budget for high-cost, large-scale collaborations. Choose DrugClaw if you are a computational biologist, researcher, or startup needing a free, self-hosted, open-source tool for molecular property prediction, virtual screening, and custom workflows without vendor lock-in.
Drugclaw vs Codametrix
For enterprise health systems seeking to slash coding costs and denials with proven automation, CodaMetrix is the clear choice—it delivers 5:1 ROI, deep EHR integration, and KLAS top ranking. DrugClaw appeals to drug discovery researchers who need a free, self-hosted AI assistant for molecular property prediction and literature mining, but it lacks enterprise support and is not for medical coding. Choose based on your domain: revenue cycle vs. pharmaceutical R&D.
Drugclaw vs Praktika
Praktika and DrugClaw serve entirely different domains—language learning vs. drug discovery. Neither is a substitute for the other. Choose Praktika if you want AI-driven speaking practice with instant feedback; choose DrugClaw if you're a researcher needing open-source tools for molecular property prediction and literature mining. Your decision depends solely on your use case, not on feature overlap.
Alternatives to DrugClaw
View all
Insilico Medicine
Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.
Schrodinger
Physics-based molecular simulation with AI for drug discovery and materials design.
Frequently Asked Questions
Categories
Best-of guides
Used DrugClaw? Help shape our editorial sentiment research.